11 hasil untuk "Aware, Chetan"
Menampilkan 1–11 · 0,22 detik · RSS
-
Artikel Jurnal Teks lengkap
Stroke‐Induced Gut Dysbiosis Increases Alzheimer's Disease Risk: Insights from Immunohistochemistry and Single‐Cell Spatial Transcriptomics
BACKGROUND: Stroke increases the risk of Alzheimer's disease (AD), but underlying mechanisms remain unclear. This study investigates whether gut dysbiosis (imbalance in gut microbes) from acute ischemic stroke worsens AD pathology. Using fecal microbiota transplantation (FMT) from stroke patients…
-
Artikel Jurnal Teks lengkap
Mucuna laticifera: unprecedented L-dopa content and its role in neurodegenerative and inflammatory conditions
Genus Mucuna encompasses several plant species renowned for their utilization in traditional Ayurvedic medicine for the treatment of Parkinson’s disease, chiefly due to their exceptionally high L-dopa content relative to other plants. However, limited information exists regarding Mucuna laticifera…
-
Artikel Jurnal Teks lengkap
Fecal microbiome transplantation from stroke donors promotes Alzheimer’s disease brain pathology and hypoperfusion in the 3xTg‐AD mice
BACKGROUND: The link between stroke and Alzheimer’s disease (AD) is recognized. However, the underlying mechanisms are not yet clear. This study seeks to determine if increased AD risk is linked to gut dysbiosis caused by acute ischemic stroke. Specifically, we examined whether fecal microbiome…
-
Artikel Jurnal Teks lengkap
iNOS knockout preserved brain perfusion despite MCI‐induced gut dysbiosis in an Alzheimer's mouse model
BACKGROUND: Inducible Nitric Oxide Synthase (iNOS) is implicated in exacerbating Alzheimer's Disease (AD) mechanisms. The relationship between imbalanced gut microbiota composition (dysbiosis) and AD pathology is well characterized. Many gut bacteria, including E. Coli induce iNOS production…
-
Artikel Jurnal Teks lengkap
The Ketogenic Diet Restores Brain Metabolism and Gut Microbiome Composition in Female APOE4 Transgenic Mice: A Multiomics Approach
BACKGROUND: The apolipoprotein ε4 (APOE4) polymorphism is the primary genetic risk factor for Alzheimer's disease (AD). APOE4 carriers exhibit early deficits in brain metabolism and gut microbiome diversity, both elevating AD risk. This study investigated whether a ketogenic diet (KD) can restore…
-
Artikel Jurnal Teks lengkap
Gut microbiome association with brain imaging markers, APOE genotype, calcium and vegetable intakes, and obesity in healthy aging adults
INTRODUCTION: Advanced age is a significant factor in changes to brain physiology and cognitive functions. Recent research has highlighted the critical role of the gut microbiome in modulating brain functions during aging, which can be influenced by various factors such as apolipoprotein E (APOE)…
-
Artikel Jurnal Teks lengkap
Prebiotic inulin enhances gut microbial metabolism and anti-inflammation in apolipoprotein E4 mice with sex-specific implications
Gut dysbiosis has been identified as a crucial factor of Alzheimer's disease (AD) development for apolipoprotein E4 (APOE4) carriers. Inulin has shown the potential to mitigate dysbiosis. However, it remains unclear whether the dietary response varies depending on sex. In the study, we fed…
-
Artikel Jurnal Teks lengkap
Ketogenic Diet Modulates Gut Microbiota–Brain Metabolite Axis in a Sex- and Genotype-Specific Manner in APOE4 Mice
The apolipoprotein E4 (APOE4) allele is the strongest genetic risk factor for late-onset Alzheimer’s disease (AD), associated with early brain metabolic dysfunction and gut microbiome alterations. Targeting these early changes through dietary interventions may reduce AD risk in asymptomatic…
-
Artikel Jurnal Teks lengkap
mTOR inhibition enhances synaptic and mitochondrial function in Alzheimer’s disease in an APOE genotype-dependent manner
Apolipoprotein ε4 (APOE4) carriers develop brain metabolic dysfunctions decades before the onset of Alzheimer’s disease (AD). A goal of the study is to identify if rapamycin, an inhibitor for the mammalian target of rapamycin (mTOR) inhibitor, would enhance synaptic and mitochondrial function in…
-
Artikel Jurnal Teks lengkap
Rapamycin enhances neurovascular, peripheral metabolic, and immune function in cognitively normal, middle-aged APOE4 Carriers: genotype-dependent effects compared to non-carriers
Rapamycin, known for its anti-aging properties, shows promise as a preventive strategy for Alzheimer’s disease (AD) in APOE4 carriers–the highest-risk group for late-onset AD. Here we show that a 4-week open-label trial of low-dose Rapamycin (Sirolimus; 1mg/day) significantly improved cerebral…